Navigation Links
Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
Date:6/2/2009

New Insights into the Prediction of IBD Using Serology Testing Also Presented

SAN DIEGO, June 2 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings regarding a correlation between an important serologic marker used in the detection of Crohn's disease and particular genetic markers in patients at risk for celiac disease. In an oral presentation yesterday at Digestive Disease Week (DDW) in Chicago, Prometheus reported a statistically significant correlation between antibodies to the flagellin CBir1 and HLA haplotypes DQ2.5 and DQ8 in a study of 5,406 patients at risk for celiac disease who are EMA positive. Blood and serum samples were analyzed using PROMETHEUS(R) Celiac PLUS and PROMETHEUS(R) IBD Serology 7 diagnostic tests.

"Genetic tests to rule out celiac disease are now readily available. However, few genetically predisposed individuals actually develop the disease, despite gluten ingestion, for reasons that are not well understood," said Dr. Michelle Pietzak, a Pediatric Gastroenterologist in the Division of Gastroenterology at the University of Southern California Keck School of Medicine. "The results from this study show that an overly aggressive immune response to particular bacteria in the intestine, as in Crohn's disease, may contribute to the inflammation seen in patients with celiac disease."

New Insights into IBD Serology Testing

Results from two additional studies regarding the prediction of inflammatory bowel disease (IBD) using serology testing were also presented yesterday at DDW. The first examined the consistency of biomarkers in patients who received multiple PROMETHEUS IBD Serology 7 tests within a two-year period. The overall rate of repeat testing ordered was only 2.2%. The results showed high concordance between the original and repeat tests; median changes in biomarker serum concentra
'/>"/>

SOURCE Prometheus Laboratories Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
2. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
3. Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Associations 69th Scientific Sessions
4. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
5. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
6. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
7. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
8. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
9. Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
10. Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II Trial for Cocaine Addiction
11. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... -- At the upcoming Radiological Society of North ...al Philips Electronics ( PHG, AEX: PHI) will demon...matics solutions designed to directly address the ...vering meaningful imaging innovations that reflect... upgradability. This focus will enable Philips to...
(Date:11/25/2009)...RNewswire/ -- Praxis Electronic Medical Records re...y of Family Physicians, (AAFP) Family Practice Man...r improving medical quality, health maintenance, a...timulus legislation. Praxis also ranked #1 among d...in determining their salary. Finally, Praxis also ...
(Date:11/25/2009)...wswire-FirstCall/ -- Heska Corporation ( HSKA); ("...ic and specialty products to the veterinary indust...ics Corporation for the supply of blood gas produc...arket. ,, (Logo: http://www.newscom.com/cg...oche share the same passion for innovating in the ...
Breaking Medicine Technology:Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 1Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 2Tianyin Pharmaceutical Co to Present at the Rodman 26 Renshaw Annual Global Investment Conference on September 11 at 10 3A50 am ET 13735 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 1Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 2Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 3Video 3A CVS pharmacy and MinuteClinic Encourage Americans to Protect Themselves Early With a Seasonal Flu Shot 55682 4IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2
...iation Scientific Sessions ...7 Nabi,Biopharmaceuticals (Nasdaq: NABI ) today ...b trial of NicVAX(R) (Nicotine Conjugate Vaccine),...ational vaccine being,developed to treat nicotine ...2-month data confirm the highly significant trends...
...i Pasteur, the vaccines division of sanofi-aventis...e II testing of its cell culture-based,seasonal in...se I was announced on Sept 25, 2006. This project,...Department of Health and,Human Services (HHS) aime...lture- based influenza vaccine. Phase II trials in...
Other Medicine Technology:Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 2Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 3Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 4Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 5Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 6Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months 7Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 2Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 3Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine 4
(Date:11/27/2009)... Three new interactive anatomy education app...ins expand health sciences learning opportunities ... Durham, NC (Vocus) November 27, 2009 -- Modali...WW), a division of Wolters Kluwer Health, today an...ation apps on the App Store. Clemente’s Anat...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... Benton Communications announces a highly ef...for retailers struggling to make an economic recov...6, 2009 -- Flu fears is the type of challenge that...room, according to Dr. David Benton, business grow...s growth system – The Rfactor Intensive . ...
(Date:11/25/2009)...ALGARY,Nov.25/PRNewswire/-SentinelleMedicalInc.,al...oilsandsoftwareandCalgaryScientificInc.,aleadingpr...dawebversionofAegis(TM)Breast4DAdvancedVisualizati...ttrulyzero-footprintWebclientbasedmedicalimagingof...atformallowsforzero-footprintaccess-requiringnosof...
(Date:11/25/2009)...ANCISCO, Nov. 25 The Bay Area Air ...s first Winter Spare the Air Aler...rning wood, manufactured firelogs or any other sol...till weather will contribute to unhealthy air qual...cer of the Air District. "We,re asking Bay Area re...
Breaking Medicine News(10 mins):Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 2Health News:Sentinelle Medical Inc. Introduces Aegis(TM) Web Powered By Calgary Scientific's PureWeb Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...g babies unattended in standard car safety seats c...ms//, according to a recent study. A study co...esearchers at the University of Auckland in New Ze...g of babies in car seats could narrow their upper ...
...le drug for multiple complaints like cholesterol, ...ng designed at Dr Reddy’s the Hyderabad-based labo...e up with a combination of four drugs — a choleste...troke by 60 per cent. It will be available in the ...
... find a combination of healthy and tasty when we d... us any option of low calorie foods//. Mostly...ies we consume each meal, as we depend on the chef...e are becoming more health conscious. At the same ...
...breast cancer patients who are still young, and ha...ait for the stipulated //two years, post-treatment... Previously, young breast cancer patients wer...ersity of Western Australia said, 'For women with ...
... cancer screening has proven helpful to abort almo...ever researchers opine that such //screening unnec...adiation. NHS offers regular screening tests ... women under the age of 50 as well, it would poten...
...y conducted by Minnesota students have revealed th...ng themselves daily are more prone to develop eati...ealthy crash diets. In spite of dieting, they end ...it, and use diet pills in order to lose weight. Pr...
Other Medicine News:Health News:Poly-pill – A Single Drug For Multiple Complaint 2Health News:Are You Health-Conscious or Tongue- Conscious? 2
Cottle Septum Elevator
Gillies Zygoma Elevator
Converse Periosteal Elevator
Converse-McKenty Periosteal Elevator
Medicine Products: